These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 20499020

  • 1. Correlation between faecal calprotectin and magnetic resonance imaging (MRI) in the evaluation of inflammatory pattern in Crohn's disease.
    Zippi M, Al Ansari N, Siliquini F, Severi C, Kagarmanova A, Maffia C, Parlanti S, Garbarino V, Maccioni F.
    Clin Ter; 2010; 161(2):e53-6. PubMed ID: 20499020
    [Abstract] [Full Text] [Related]

  • 2. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R.
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [Abstract] [Full Text] [Related]

  • 3. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
    Guidi L, Marzo M, Andrisani G, Felice C, Pugliese D, Mocci G, Nardone O, De Vitis I, Papa A, Rapaccini G, Forni F, Armuzzi A.
    Dig Liver Dis; 2014 Nov; 46(11):974-9. PubMed ID: 25096964
    [Abstract] [Full Text] [Related]

  • 4. Faecal calprotectin in the assessment of Crohn's disease activity.
    Gaya DR, Lyon TD, Duncan A, Neilly JB, Han S, Howell J, Liddell C, Stanley AJ, Morris AJ, Mackenzie JF.
    QJM; 2005 Jun; 98(6):435-41. PubMed ID: 15879440
    [Abstract] [Full Text] [Related]

  • 5. A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease.
    Naismith GD, Smith LA, Barry SJ, Munro JI, Laird S, Rankin K, Morris AJ, Winter JW, Gaya DR.
    Aliment Pharmacol Ther; 2013 Mar; 37(6):613-21. PubMed ID: 23347334
    [Abstract] [Full Text] [Related]

  • 6. Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings.
    Sipponen T, Kärkkäinen P, Savilahti E, Kolho KL, Nuutinen H, Turunen U, Färkkilä M.
    Aliment Pharmacol Ther; 2008 Nov 15; 28(10):1221-9. PubMed ID: 18752630
    [Abstract] [Full Text] [Related]

  • 7. Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics.
    Oyaert M, Trouvé C, Baert F, De Smet D, Langlois M, Vanpoucke H.
    Clin Chem Lab Med; 2014 Mar 15; 52(3):391-7. PubMed ID: 24114912
    [Abstract] [Full Text] [Related]

  • 8. Faecal calprotectin: a new marker for Crohn's disease?
    Wassell J, Dolwani S, Metzner M, Losty H, Hawthorne A.
    Ann Clin Biochem; 2004 May 15; 41(Pt 3):230-2. PubMed ID: 15117438
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology.
    Dolwani S, Metzner M, Wassell JJ, Yong A, Hawthorne AB.
    Aliment Pharmacol Ther; 2004 Sep 15; 20(6):615-21. PubMed ID: 15352909
    [Abstract] [Full Text] [Related]

  • 10. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
    Schoepfer AM, Beglinger C, Straumann A, Trummler M, Vavricka SR, Bruegger LE, Seibold F.
    Am J Gastroenterol; 2010 Jan 15; 105(1):162-9. PubMed ID: 19755969
    [Abstract] [Full Text] [Related]

  • 11. Faecal calprotectin and magnetic resonance imaging in detecting Crohn's disease endoscopic postoperative recurrence.
    Baillet P, Cadiot G, Goutte M, Goutorbe F, Brixi H, Hoeffel C, Allimant C, Reymond M, Obritin-Guilhen H, Magnin B, Bommelaer G, Pereira B, Hordonneau C, Buisson A.
    World J Gastroenterol; 2018 Feb 07; 24(5):641-650. PubMed ID: 29434453
    [Abstract] [Full Text] [Related]

  • 12. Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment.
    Sipponen T, Björkesten CG, Färkkilä M, Nuutinen H, Savilahti E, Kolho KL.
    Scand J Gastroenterol; 2010 Mar 07; 45(3):325-31. PubMed ID: 20034360
    [Abstract] [Full Text] [Related]

  • 13. Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study.
    Laharie D, Mesli S, El Hajbi F, Chabrun E, Chanteloup E, Capdepont M, Razaire S, de Lédinghen V, Zerbib F.
    Aliment Pharmacol Ther; 2011 Aug 07; 34(4):462-9. PubMed ID: 21671970
    [Abstract] [Full Text] [Related]

  • 14. Crohn's disease: small bowel motility impairment correlates with inflammatory-related markers C-reactive protein and calprotectin.
    Bickelhaupt S, Pazahr S, Chuck N, Blume I, Froehlich JM, Cattin R, Raible S, Bouquet H, Bill U, Rogler G, Frei P, Boss A, Patak MA.
    Neurogastroenterol Motil; 2013 Jun 07; 25(6):467-73. PubMed ID: 23495824
    [Abstract] [Full Text] [Related]

  • 15. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease.
    Costa F, Mumolo MG, Ceccarelli L, Bellini M, Romano MR, Sterpi C, Ricchiuti A, Marchi S, Bottai M.
    Gut; 2005 Mar 07; 54(3):364-8. PubMed ID: 15710984
    [Abstract] [Full Text] [Related]

  • 16. Effect of faecal calprotectin assay variability on the management of inflammatory bowel disease and potential role of faecal S100A12.
    Whitehead SJ, Ford C, Gama RM, Ali A, McKaig B, Waldron JL, Steed H, Brookes MJ.
    J Clin Pathol; 2017 Dec 07; 70(12):1049-1056. PubMed ID: 28735301
    [Abstract] [Full Text] [Related]

  • 17. Biochemical markers and MR imaging findings as predictors of crohn disease activity in patients scanned by contrast-enhanced MR enterography.
    Quaia E, Cabibbo B, Sozzi M, Gennari AG, Pontello M, Degrassi F, Cova MA.
    Acad Radiol; 2014 Oct 07; 21(10):1225-32. PubMed ID: 24998692
    [Abstract] [Full Text] [Related]

  • 18. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
    Chang MH, Chou JW, Chen SM, Tsai MC, Sun YS, Lin CC, Lin CP.
    Mol Med Rep; 2014 Jul 07; 10(1):522-6. PubMed ID: 24788223
    [Abstract] [Full Text] [Related]

  • 19. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
    Kotze LM, Nisihara RM, Marion SB, Cavassani MF, Kotze PG.
    Arq Gastroenterol; 2015 Jul 07; 52(1):50-4. PubMed ID: 26017083
    [Abstract] [Full Text] [Related]

  • 20. Diffusion-weighted imaging for evaluating inflammatory activity in Crohn's disease: comparison with histopathology, conventional MRI activity scores, and faecal calprotectin.
    Pendsé DA, Makanyanga JC, Plumb AA, Bhatnagar G, Atkinson D, Rodriguez-Justo M, Halligan S, Taylor SA.
    Abdom Radiol (NY); 2017 Jan 07; 42(1):115-123. PubMed ID: 27567607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.